Optimizing dendritic cell-based immunotherapy in multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2002-05-01 / Br. J. Haematol. 2002 May;117(2):297-305Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
/in International Publications, Newcastle Disease Virus /von 2002-05-01 / J. Clin. Oncol. 2002 May;20(9):2251-66A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models
/in Hyperthermia, International Publications /von 2002-05-01 / Int J Hyperthermia 2002 May-Jun;18(3):253-66Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus
/in Chronic Virus Hepatitis, International Publications /von 2002-05-01 / Hepatol. Res. 2002 May;23(1):38-47
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution